N-(5-(叔丁基)异恶唑-3-基)-2-氯乙酰胺结构式
|
常用名 | N-(5-(叔丁基)异恶唑-3-基)-2-氯乙酰胺 | 英文名 | N-(5-(tert-Butyl)isoxazol-3-yl)-2-chloroacetamide |
|---|---|---|---|---|
| CAS号 | 55809-27-3 | 分子量 | 216.66500 | |
| 密度 | 1.226g/cm3 | 沸点 | 377.1ºC at 760 mmHg | |
| 分子式 | C9H13ClN2O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 181.9ºC |
| 中文名 | N-(5-(叔丁基)异恶唑-3-基)-2-氯乙酰胺 |
|---|---|
| 英文名 | N-(5-tert-butyl-1,2-oxazol-3-yl)-2-chloroacetamide |
| 密度 | 1.226g/cm3 |
|---|---|
| 沸点 | 377.1ºC at 760 mmHg |
| 分子式 | C9H13ClN2O2 |
| 分子量 | 216.66500 |
| 闪点 | 181.9ºC |
| 精确质量 | 216.06700 |
| PSA | 55.13000 |
| LogP | 2.22240 |
| InChIKey | MZAGTAPJCLVZHA-UHFFFAOYSA-N |
| SMILES | CC(C)(C)c1cc(NC(=O)CCl)no1 |
| 折射率 | 1.525 |
| 储存条件 | 2-8°C, 惰性气体 |
| 海关编码 | 2934999090 |
|---|
|
~95%
N-(5-(叔丁基)异恶唑-3... 55809-27-3 |
| 文献:MERCK PATENT GMBH Patent: WO2004/19941 A1, 2004 ; Location in patent: Page/Page column 158 ; WO 2004/019941 A1 |
| N-(5-(叔丁基)异恶唑-3-基)-2-氯乙酰胺上游产品 2 | |
|---|---|
| N-(5-(叔丁基)异恶唑-3-基)-2-氯乙酰胺下游产品 0 | |
| 海关编码 | 2934999090 |
|---|---|
| 中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
实验名称:Inhibition of EGFR-TK (unknown origin) relative to control
来源:ChEMBL
靶标:Epidermal growth factor receptor
External Id:CHEMBL4672269
|
|
实验名称:Inhibition of EGFR-TK (unknown origin) at 10 uM relative to control
来源:ChEMBL
靶标:Epidermal growth factor receptor
External Id:CHEMBL4672237
|
|
实验名称:Antitumor activity against human MCF7 cells assessed as inhibition of cell viability ...
来源:ChEMBL
靶标:MCF7
External Id:CHEMBL4672273
|
|
实验名称:Antitumor activity against human HCT-116 cells assessed as inhibition of cell viabili...
来源:ChEMBL
靶标:HCT-116
External Id:CHEMBL4672272
|
|
实验名称:Antitumor activity against human HepG2 cells assessed as inhibition of cell viability...
来源:ChEMBL
靶标:HepG2
External Id:CHEMBL4672275
|